The advocates of proposition 19, the bill that tried to legalize
cannabis in California, must be turning cartwheels at the news coming
out of University of California, San Diego School of Medicine. It's
especially ironic coming just a few weeks after the Federal raid and
almost complete shutdown of Oaksterdam University, the privately run
school in Oakland, California that teaches students how to grow and
harvest the much derided herb.
A clinic trial of 30 adult patients suffering from Multiple Sclerosis appears to have demonstrated its ability to reduce spasticity and pain, when compared to a placebo.
Multiple Sclerosis is a degenerative disease that affects the lining of the nerve fibers and reduces their ability to transmit properly, a little like an electrical cable with worn insulation. It can also cause ulceration on the brain. Like Parkinson's and Alzheimer's it's a slow and degenerative disease, without a cure, thus the best hope for doctors is finding treatments that reduce symptoms and slow the progression.
The findings of principal investigator Jody Corey-Bloom, MD, PhD, professor of neurosciences and director of the Multiple Sclerosis Center at UC San Diego, and her colleagues will be published in Canadian Medical Association Journal this month.
In short, the trial was conducted by dividing the group in two parts, one half smoked placebo cannabis for three days, while the remaining half had the real thing. The scientists then swapped over the supply so the placebo group smoked the real thing and visa versa. The researchers didn't mention whether or not anyone cheating by scoring their own supplies on top.
There have been previous studies that looked into the possibility of treating neurological conditions with cannabis, but they mainly focused on oral treatments, presumably because smoking was considered unhealthy. However, with a recent report showing that cannabis smokers are not affected nearly as badly as tobacco smokers
SOURCES: http://www.medicalnewstoday.com/articles/245424.php
A clinic trial of 30 adult patients suffering from Multiple Sclerosis appears to have demonstrated its ability to reduce spasticity and pain, when compared to a placebo.
Multiple Sclerosis is a degenerative disease that affects the lining of the nerve fibers and reduces their ability to transmit properly, a little like an electrical cable with worn insulation. It can also cause ulceration on the brain. Like Parkinson's and Alzheimer's it's a slow and degenerative disease, without a cure, thus the best hope for doctors is finding treatments that reduce symptoms and slow the progression.
The findings of principal investigator Jody Corey-Bloom, MD, PhD, professor of neurosciences and director of the Multiple Sclerosis Center at UC San Diego, and her colleagues will be published in Canadian Medical Association Journal this month.
In short, the trial was conducted by dividing the group in two parts, one half smoked placebo cannabis for three days, while the remaining half had the real thing. The scientists then swapped over the supply so the placebo group smoked the real thing and visa versa. The researchers didn't mention whether or not anyone cheating by scoring their own supplies on top.
There have been previous studies that looked into the possibility of treating neurological conditions with cannabis, but they mainly focused on oral treatments, presumably because smoking was considered unhealthy. However, with a recent report showing that cannabis smokers are not affected nearly as badly as tobacco smokers
SOURCES: http://www.medicalnewstoday.com/articles/245424.php
0 comments:
Post a Comment